3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
2
Head and Neck Neoplasms
2
Salivary Gland Neoplasms
1
Recurrence
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Klatskin Tumor
1
Cholangiocarcinoma
1
Carcinoma, Squamous Cell
1
Interventions
Fluorouracil
4
Oxaliplatin
3
Capecitabine
3
toripalimab
2
dehydroftorafur
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Biopsy
2
tremelimumab
1
trametinib
1
tislelizumab
1
temoporfin
1
sacituzumab govitecan
1
lenvatinib
1
gemcitabine-oxaliplatin regimen
1
durvalumab
1
binimetinib
1
Stents
1
Sorafenib
1
Radiosurgery
1
Hydroxychloroquine
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Cisplatin
1
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Klatskin Tumor
×
temoporfin
×
Clear all
NCT03003065
2023-08-22
PDT
Chinese University of Hong Kong
Phase 2
Completed
10 enrolled